ADVENZYMESNSEADVANCED ENZYME TECH LTD· Pharmaceuticals & BiotechnologyHighPositive
Announced Wed, 7 Oct, 2026 · 15:32 IST

Advanced Enzyme extinguishes 8.88 lakh shares under ongoing buyback

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹269.25
prior close
₹271.05
announcement price
After-mkt
timing
Nifty Microcap 250market-2.8%+1.7% vs market
Biotechnology peers, median of 5sector-2.1%+1.1% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.1 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.6
15m
-0.2
30m
-1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1-2.8+1.7-2.1+1.1
Next day
-1.2-2.5+1.3-2.4+1.2
2d
-1.2-1.7+0.5-1.0-0.1
3d
-0.8-1.5+0.7-1.9+1.1
4d
-0.1-0.8+0.7-4.5+4.4
5d
-1.9-2.4+0.5——
1w
-2.4-3.4+1.0-2.1-0.2
15d
-3.4pendingpending-6.4+3.0
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Advanced Enzyme Technologies has extinguished 8,88,296 equity shares (face value Rs 2 each) bought back during September 2026 under its ongoing open market buyback through stock exchanges. Paid-up share capital has reduced to about Rs 22.05 crore from Rs 22.23 crore, with total shares extinguished till date at 17,13,324. The buyback was announced on August 10, 2026.

Likely market impact

Reduces outstanding share count, which can lift per-share metrics like EPS. Signals ongoing capital return to shareholders through the buyback route.